Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tempest Therapeutics Q4 EPS $(0.63) Beats $(0.76) Estimate

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share
byHappy Mohamed
March 23, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts